Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Rev. mex. cardiol ; 29(2): 102-111, Apr.-Jun. 2018. graf
Artigo em Inglês | LILACS | ID: biblio-1020708

RESUMO

Abstract: Background: Aortic stenosis is the most common valvular heart disease worldwide. The prognosis is adverse without a valve replacement. Transcatheter aortic valve implantation (TAVI) has proven to be an effective treatment in high-surgical risk patients. Recent trials have highlighted the non-inferiority of TAVI compared with open surgery in patients with intermediate surgical risk. Case report: A 76-year-old man with severe aortic stenosis and intermediate surgical risk (STS-PROM 4.8%) who underwent TAVI with no complications. Results: Hospital discharge was decided five days after the procedure and continued outpatient follow-up. After two years remains in NYHA functional class I with a normofunctional percutaneous prosthesis. Conclusion: As this clinical case shows, TAVI has proven to be an effective treatment in patients with aortic stenosis and intermediate surgical risk. This is the first experience in this type of patients reported in our country.(AU)


Resumen: Antecedentes: La estenosis aórtica es la valvulopatía más común en todo el mundo. El pronóstico es sombrío sin reemplazo valvular. La implantación valvular aórtica transcatéter (TAVI) ha demostrado ser un tratamiento eficaz en pacientes de alto riesgo quirúrgico. Ensayos muy recientes destacaron la no-inferioridad de TAVI en comparación con la cirugía abierta en pacientes con riesgo quirúrgico intermedio. Caso clínico: Se presenta un hombre de 76 años de edad con estenosis aórtica severa y riesgo quirúrgico intermedio (STS-PROM 4.8%), al que se realiza TAVI sin complicaciones. Resultados: El alta hospitalaria se decide cinco días después del procedimiento para continuar el seguimiento ambulatorio. Después de dos años, el seguimiento permanece en la clase funcional I de la NYHA con una prótesis percutánea normofuncional. Conclusión: Como muestra este caso clínico, TAVI ha demostrado ser un tratamiento eficaz en pacientes de riesgo quirúrgico intermedio. Ésta es la primera experiencia en el uso de esta tecnología en este tipo de pacientes reportada en nuestro país.(AU)


Assuntos
Humanos , Masculino , Estenose da Valva Aórtica/cirurgia , Substituição da Valva Aórtica Transcateter/instrumentação , Doenças das Valvas Cardíacas/fisiopatologia , Medição de Risco
4.
Cardiovasc Revasc Med ; 18(5S1): S27-S29, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28412039

RESUMO

Coronary trifurcation lesions are a complex subset of lesions and are substantially more complex than bifurcations when treated with percutaneous coronary intervention (PCI) because of higher rates of acute periprocedural complications (dissection, myocardial infarction, acute vessel closure) and less effective long-term outcomes (stent thrombosis, restenosis) as compared to non-bifurcation lesions. We present the case of a 73-year-old man who was admitted to our hospital with symptomatic severe aortic stenosis who was found to have a distal left main trifurcation disease as well as porcelain aorta on work-up. Given the high risk of stroke during surgical aortic valve replacement and coronary artery bypass grafting, the patient was accepted by the heart team to proceed with percutaneous coronary intervention (PCI) and trans-catheter aortic valve replacement (TAVR). We describe a successful double mini-crush stenting technique approach for this case.


Assuntos
Estenose da Valva Aórtica/cirurgia , Estenose Coronária/terapia , Stents Farmacológicos , Substituição da Valva Aórtica Transcateter , Idoso , Estenose da Valva Aórtica/diagnóstico , Ponte de Artéria Coronária/efeitos adversos , Estenose Coronária/diagnóstico , Stents Farmacológicos/efeitos adversos , Humanos , Masculino , Intervenção Coronária Percutânea/efeitos adversos , Intervenção Coronária Percutânea/métodos , Substituição da Valva Aórtica Transcateter/métodos , Resultado do Tratamento
5.
Rev. mex. cardiol ; 28(1): 40-46, Jan.-Mar. 2017. graf
Artigo em Inglês | LILACS | ID: biblio-902320

RESUMO

Abstract: Background: Intramyocardial dissecting haematoma is a rare form of cardiac rupture that can occur as a complication following acute myocardial infarction or during the remodelling process, with very scarce reports in medical literature. Usually caused by a haemorrhagic dissection among the spiral myocardial fibres. Case report: Here we report the case of a 60-year-old man with a previous infarction in the inferior wall extended to the right ventricle, in whom a dissecting intramyocardial haematoma in the free wall of the right ventricle was identified using transthoracic and contrast echocardiography, corroborated with cardiac magnetic resonance. Results: By this imaging modalities, it was possible to see the various acoustic densities of the progressive clotting of the hematoma, its extension through the haemorrhagic dissection, as well as its independency in relation to ventricular cavities and extracardiac space by confirming intact epicardial and endocardial layers. Conclusion: The patient presented a gradual improvement and hemodynamic stability, and basing on the existent medical literature, it was decided the medical treatment as the therapeutic option, maintaining asymptomatic after three months of follow-up.


Resumen: Antecedentes: El hematoma intramiocárdico disecante es una forma rara de ruptura cardiaca que puede ocurrir como una complicación posterior al infarto agudo de miocardio o durante el proceso de remodelación del mismo, con informes muy escasos en la literatura médica. Generalmente causada por una disección hemorrágica entre las fibras espirales del miocardio. Caso clínico: Se presenta el caso de un hombre de 60 años con infarto previo en la pared inferior extendido al ventrículo derecho, en el que se identificó un hematoma intramiocárdico disecante en la pared libre del ventrículo derecho mediante ecocardiografía transtorácica y contrastada, corroborado con resonancia magnética cardiaca. Resultados: Por medio de estas modalidades de imagen se pudieron observar las distintas densidades acústicas de la coagulación progresiva del hematoma, su extensión a través de la disección hemorrágica, así como su independencia en relación con las cavidades ventriculares y el espacio extracardiaco, confirmando las capas epicárdicas y endocárdicas indemnes. Conclusión: El paciente presentó una mejoría gradual y estabilidad hemodinámica, y basándose en la literatura médica existente, se decidió el tratamiento médico como opción terapéutica, manteniéndose asintomático después de tres meses de seguimiento.

6.
Rev. mex. cardiol ; 27(4): 166-170, Oct.-Dec. 2016. graf
Artigo em Inglês | LILACS | ID: biblio-845425

RESUMO

Abstract: Introduction: A case report describing the use of bio-absorbable vascular scaffolds in a patient with rare anomalous origin of right coronary artery. Case report: Male 71 years, ST-segment elevation myocardial infarction in the inferior region wall, thrombolysis with tenecteplase, with reperfusion criteria. Coronary angiography: left coronary system without angiographic lesions, right coronary artery with a significant lesion in the middle segment. An elective percutaneous coronary intervention was performed using 2 bio-absorbable vascular scaffolds (Absorb 3.5 x 28 mm joined in proximal segment with an Absorb 3.5 x 23 mm), posterior review with optical coherence tomography. Results: Discharged 24 hours later, remaining asymptomatic at 6 months follow-up. Conclusion: In this case, the significant stenosis of the artery involved was treated with the implantation of two bio-absorbable vascular scaffolds, obtaining an appropriate outcome after six months follow-up. This is the first report of a patient with anomalous origin of the right coronary artery treated with bio-absorbable vascular scaffolds in Mexico.


Resumen: Introducción: Se trata de un caso clínico que describe el uso de stents bioabsorbibles en un paciente con origen anómalo de arteria coronaria derecha de rara presen­tación. Caso clínico: Hombre de 71 años, con antecedente de infarto del miocardio con elevación del segmento ST en la cara inferior, sometido a trombolisis con tenecteplase, presentando criterios de reperfusión. El angiograma coronario reporta el sistema coronario izquierdo sin lesiones significativas, así como la arteria coronaria derecha con una lesión significativa en el segmento proximal a medio. Se realizó una intervención coronaria percutánea electiva con dos stents bioabsorbibles (Absorb 3.5 x 28 mm el cual se empalmó en el segmento proximal con un Absorb 3.5 x 23 mm), revisión posterior con tomografía de coherencia óptica con adecuada aposición. Resultados: Egresado 24 horas más tarde, permaneciendo asintomático a los seis meses de seguimiento. Conclusión: En este caso, la estenosis significativa de la arteria involucrada fue tratada con la implantación de dos stents bioabsorbibles, con la obtención de un resultado clínico apropiado después de seis meses de seguimiento. Éste es el primer informe de un paciente con un origen anómalo de la arteria coronaria derecha tratado con stents bioabsorbibles en México.

7.
Asian Cardiovasc Thorac Ann ; 24(1): 57-9, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24904176

RESUMO

We report the case of 23-year-old man with mitral valve regurgitation and Glanzmann thrombasthenia, who underwent mechanical mitral valve replacement. Warfarin therapy was devastating, causing bilateral hemothorax, pericardial effusion, gastrointestinal bleeding, and hematuria. Redo mitral valve replacement with a biological prosthesis was required to resolve this critical situation. To our knowledge, this is the first report of mitral valve replacement in Glanzmann thrombasthenia, highlighting the danger of oral anticoagulation in this pathology.


Assuntos
Anticoagulantes/efeitos adversos , Coagulação Sanguínea , Implante de Prótese de Valva Cardíaca , Insuficiência da Valva Mitral/cirurgia , Valva Mitral/cirurgia , Hemorragia Pós-Operatória/induzido quimicamente , Trombastenia/complicações , Varfarina/efeitos adversos , Administração Oral , Anticoagulantes/administração & dosagem , Bioprótese , Coagulação Sanguínea/genética , Remoção de Dispositivo , Hemorragia Gastrointestinal/induzido quimicamente , Próteses Valvulares Cardíacas , Implante de Prótese de Valva Cardíaca/instrumentação , Hematúria/induzido quimicamente , Humanos , Masculino , Insuficiência da Valva Mitral/complicações , Insuficiência da Valva Mitral/diagnóstico , Derrame Pericárdico/induzido quimicamente , Hemorragia Pós-Operatória/diagnóstico , Desenho de Prótese , Reoperação , Fatores de Risco , Trombastenia/sangue , Trombastenia/diagnóstico , Resultado do Tratamento , Varfarina/administração & dosagem , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...